Patient Care Related Content

A new risk-stratification tool has been developed by researchers from the UK Coronavirus Clinical Characterisation Consortium and can accurately predict the likelihood of deterioration in hospitalised COVID-19 patients.

Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.

Here, José Bastos, Director at knok, explores how virtual care management will be fundamental to digital transformation within the healthcare sector.

Here, we discover that FebriDx® rapid point of care triage can help prevent the spread of infection and improve patient streaming.

Olivia Burr, Inpatient Care Lead at Diabetes UK, explains how COVID-19 has renewed momentum to improve inpatient diabetes care.

Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.

Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.

Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.

Helen Dempster, Founder of Karantis360, explores the benefits of Spark DPS and what future developments are required to improve the public sector health procurement journey even further.

Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus

Leading pancreatic cancer experts Professor Matthias Löhr and Professor Monique van Leerdam of United European Gastroenterology’s (UEG) Public Affairs Committee discuss the importance of early diagnosis and the latest developments in treatment for pancreatic cancer.

Imperial College London are working on clinical trials of a kisspeptin drug that could treat PCOS, HA and other reproductive health problems.

Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.

Muy-Teck Teh, Senior Lecturer from Barts and the London School of Medicine & Dentistry, Queen Mary University of London discusses how a novel low-cost rapid digital diagnostic test could help save lives and reduce head and neck cancer burden worldwide.

Elena Posth & Romina Männl from Pfalzklinikum walk us through exactly how the company has entered into a new and exciting era of treating people with mental illness by charting their ‘Innovative psychiatry for the 21st century – Close to domicile. Competent. Human’ project.

Findings from a new study have cites that hospital floors are a hotspot for bacteria to breed, creating a route of transfer to patients.

According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.

A new study, led by researchers at Queen Mary University of London, uses novel biomarkers to predict patient responsiveness to rheumatoid arthritis treatment.

Dr Owain Rhys Hughes, founder and CEO of Cinapsis, explores how remote GP consultations are providing opportunities for both patients and the NHS.